The upstart broker that made trading easy got blasted at a Congressional hearing. Read More
Related Articles
Congress loves a Big Pharma villain. But will that lead to any real policy changes on drug prices?
Posted on Author admin
AbbVie has never been shy about guarding its patents and hiking drug prices. Congress tore into the company this week. But will it lead to any real policy change? Read More
Most influential U.S. business group threatens to withhold campaign funds—but doesn’t call for Trump’s ouster
Posted on Author admin
The U.S. Chamber of Commerce is threatening to withhold campaign funds from politicians who railed against approval of Joe Biden’s election victory, but it wouldn’t identify which ones, nor did it call for the ouster of President Donald Trump after last week’s insurrection at the Capitol. The chamber, among the most powerful business groups in […]
There are smarter ways to think about board diversity, and the pressure is on companies to figure them out
Posted on Author admin
Speaking out against questionable management can pose a risk for tech workers in the minority—but that’s about to change by an act of solidarity. Read More